Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection
Loading...
Authors
Rosadas, Carolina
Brites, Carlos
Arakaki-Sanchez, Denise
Casseb, Jorge
Ishak, Ricardo
Issue Date
2021-05-17
Type
Article
Language
en_US
Keywords
Human T-Cell Lymphotropic Virus 1 , Sexually Transmitted Diseases , Diagnosis , Signs and Symptoms , Disease Prevention
Alternative Title
Abstract
This article addresses the Human T-lymphotropic virus (HTLV). This subject comprises the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health. HTLV-1/2 infection is a public health problem globally, and Brazil has the largest number of individuals living with the virus. HTLV-1 causes several clinical manifestations of neoplasm (adult T-cell leukemia/lymphoma) and inflammatory nature, such as HTLV-1-associated myelopathy and other manifestations such as uveitis, arthritis, and infective dermatitis. These pathologies have high morbidity and mortality and negatively impact the quality of life of infected individuals. This review includes relevant information for health authorities professionals regarding viral transmission, diagnosis, treatment, and monitoring of individuals living with HTLV-1 and 2 in Brazil.
Description
Citation
Rosadas, C., Brites, C., Arakaki-Sanchez, D., Casseb, J., & Ishak, R. (2021). Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection. Revista da Sociedade Brasileira de Medicina Tropical, 54(suppl 1), e2020605. https://doi.org/10.1590/0037-8682-605-2020
Publisher
Journal of the Brazilian Society of Tropical Medicine